Browsing: Uncategorized


Patients with recurrent glioblastoma multiforme – the most aggressive form of primary brain tumor – treated with an experimental vaccine made from the patient’s own resected tumor tissue showed an improved survival rate when compared with historical patients who received the standard of care alone, according to an analysis of a phase 2 trial of this vaccine.

1 2 3 4 55